Sandu Pharmaceuticals share price
You have to be logged in to add this to Watchlist.Sandu Pharmaceuticals is trading 0.03% upper at Rs 57.82 as compared to its last closing price. Sandu Pharmaceuticals has been trading in the price range of 59.15 & 57.00. Sandu Pharmaceuticals has given -15.12% in this year & -0.29% in the last 5 days.
Sandu Pharmaceuticals has TTM P/E ratio 36.63 as compared to the sector P/E of 50.85.
The company posted a net profit of 0.17 Crores in its last quarter.
Listed peers of Sandu Pharmaceuticals include Gujarat Terce Laboratories (-1.99%), Vivo Bio Tech (5.21%), Sandu Pharmaceuticals (0.03%) etc.
Sandu Pharmaceuticals has a 57.10% public holding.
Sandu Pharmaceuticals share price range
|
| ||||
|
| ||||
Sandu Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 55.84 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Sandu Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 14-Nov-24 | Quarterly Results |
| 12-Aug-24 | Quarterly Results & Final Dividend |
| 05-Jun-24 | Audited Results |
| 30-May-24 | Audited Results |
| 30-Mar-24 | Others |
| 14-Feb-24 | Quarterly Results |
| 13-Nov-23 | Quarterly Results |
| 14-Aug-23 | Quarterly Results & Final Dividend |
| 30-May-23 | Audited Results |
| 14-Feb-23 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 30-Sep-24 | 14-Aug-24 | AGM |
| 30-Sep-23 | 14-Aug-23 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 14-Aug-24 | - | 19-Sep-24 | 0.8 |
| 14-Aug-23 | - | 18-Sep-23 | 0.75 |
| 12-Aug-22 | - | 23-Sep-22 | 0.75 |
| 16-Aug-21 | - | 22-Sep-21 | 0.5 |
FAQs about Sandu Pharmaceuticals share price
Sandu Pharmaceuticals is trading at 57.82 as on Tue Nov 26 2024 09:51:03. This is 0.03% upper as compared to its previous closing price of 57.80.
The market capitalization of Sandu Pharmaceuticals is 55.84 Cr as on Tue Nov 26 2024 09:51:03.
The 52 wk high for Sandu Pharmaceuticals is 85.00 whereas the 52 wk low is 54.00
Sandu Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 36.63
- Sector P/E: 50.85
- Dividend Yield: 1.38%
- D/E ratio: -
Sandu Pharmaceuticals reported a net profit of 1.46 Cr in 2024.
Sandu Pharmaceuticals Quick Links
Sandu Pharmaceuticals Dividend Sandu Pharmaceuticals Bonus Sandu Pharmaceuticals News Sandu Pharmaceuticals AGM Sandu Pharmaceuticals Rights Sandu Pharmaceuticals Splits Sandu Pharmaceuticals Board Meetings Sandu Pharmaceuticals Key Metrics Sandu Pharmaceuticals Shareholdings Sandu Pharmaceuticals Profit Loss Sandu Pharmaceuticals Balance Sheet Sandu Pharmaceuticals Cashflow Sandu Pharmaceuticals Q1 Results Sandu Pharmaceuticals Q2 Results Sandu Pharmaceuticals Q3 Results Sandu Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks